Pharmaceutical composition for intracellular acidification with cis-urocanic acid
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 18, 2014
Grant Date -
Dec 13, 2012
app pub date -
Aug 14, 2012
filing date -
Mar 14, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A pharmaceutically acceptable agent able to acidify the cell cytoplasm, for the manufacture of a pharmaceutical composition useful for causing immunosuppression in a person or animal, where an effective amount of the agent is administered in an essentially non-dissociated form to the person or animal, and where the agent is admixed with a carrier to adjust the pH of the composition to the pH range 6.1 to 7.0. A pharmaceutical composition is also disclosed.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully